Rheumatoid arthritis (RA) is a chronic autoimmune disorder that significantly impacts the quality of life, causing joint damage, pain, and systemic complications. While traditional treatments have improved patient outcomes, there is a growing need for innovative therapies to address unmet challenges in disease management. This course provides a comprehensive review of emerging therapeutics in RA, highlighting novel biologics, targeted synthetic DMARDs, and other advancements. Designed for healthcare professionals, it offers valuable insights into the latest treatment strategies, enabling improved patient care and disease control.